Use of activated coagulation factor vii to treat major bleeds induced in thrombolytic therapy

摘要

"USE OF ACTIVATED COAGULATION FACTOR VII FOR TREATMENT OF MAIN BLEEDS INDUCED IN THROMBOLYTIC THERAPY". The invention relates to major thrombolytic / fibrinolytic therapy-induced bleeds, including intracranial hemorrhages which are treated by administering to the subject suffering from such bleeds an effective amount of activated clotting factor VII (VIIa) or a functional derivative thereof.